MeSH term
Frequency | Condition_Probility | Adult | 2 | 0.0 |
Aged | 3 | 0.0 |
Aged, 80 and over | 2 | 0.0 |
Antigens, Neoplasm/*genetics | 7 | 11.0 |
Female | 10 | 0.0 |
Humans | 24 | 0.0 |
Middle Aged | 4 | 0.0 |
Neoplasm Proteins/*genetics | 4 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 7 | 0.0 |
Antigens, Neoplasm/*biosynthesis/genetics | 2 | 11.0 |
Blotting, Northern | 2 | 0.0 |
Immunohistochemistry | 2 | 0.0 |
Male | 12 | 0.0 |
Research Support, Non-U.S. Gov't | 15 | 0.0 |
Tumor Cells, Cultured | 7 | 0.0 |
Comparative Study | 4 | 0.0 |
Gene Expression | 7 | 0.0 |
RNA, Messenger/metabolism | 3 | 0.0 |
Animals | 4 | 0.0 |
Immunotherapy/*methods | 2 | 1.0 |
Neoplasm Proteins/genetics | 4 | 0.0 |
Amino Acid Sequence | 5 | 0.0 |
Melanoma/*immunology | 2 | 2.0 |
Molecular Sequence Data | 5 | 0.0 |
Neoplasm Proteins/*immunology | 2 | 5.0 |
T-Lymphocytes, Cytotoxic/*immunology | 4 | 0.0 |
Antigens, Neoplasm/genetics | 2 | 7.0 |
Base Sequence | 3 | 0.0 |
Cloning, Molecular | 2 | 0.0 |
DNA, Complementary/genetics | 3 | 0.0 |
*Gene Expression Regulation, Neoplastic | 3 | 0.0 |
*Membrane Proteins | 2 | 0.0 |
Polymerase Chain Reaction | 2 | 0.0 |
Gene Expression Regulation, Neoplastic | 3 | 0.0 |
Melanoma/genetics/*immunology | 2 | 13.0 |
Organ Specificity | 2 | 0.0 |
Antigens, Neoplasm/*metabolism | 2 | 2.0 |
Case-Control Studies | 2 | 0.0 |
*DNA Helicases | 2 | 0.0 |
